Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Galapagos Says Goodbye To Jyseleca And Streamlines Operations

Oct 31 2023

• By Kevin Grogan

Alfasigma — Jyseleca will soon be in Italian hands • Source: N. Biddau/Alfasigma

Related Content

Galapagos Loses Potential Ticket To America As Crohns Trial Flops

Feb 09 2023

Galapagos Could Give Up On Jyseleca Over JAK Class Woes

Aug 04 2023

EMA Recommends New Measures For JAK Inhibitors After Confirming Serious Risks

Oct 28 2022

Italy’s Alfasigma Comes Calling After Intercept’s Cruel Summer

Sep 26 2023

Related Companies

Galapagos NV

Gilead Sciences, Inc.

Johnson & Johnson

Intercept Pharmaceuticals, Inc.

Additional Topics

Business Strategies Deals Restructuring Commercial Immune Disorders Inflammation Gastrointestinal BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window